Zivo Bioscience transitions to OTCID marketplace

Zivo Bioscience, Inc. (OTCID: ZIVO) announced that its common stock has transitioned to quotation on the OTCID marketplace. The company began trading on OTCID as of May 11, 2026.

The OTCID marketplace is an OTC Markets tier for companies that publish baseline disclosure and maintain current information through OTC Markets' disclosure systems. The transition allows companies to maintain public trading with streamlined reporting requirements and improved flexibility.

"This transition supports our commitment to transparency and continued access for our shareholders," said John B. Payne, CEO. "Completing OTC Markets' review process and moving to OTCID allows us to focus on advancing our scientific and commercial objectives while maintaining an efficient public‑market presence."

The company will continue to provide required corporate and financial information through its OTC Markets disclosure page in accordance with applicable standards. All existing shareholders retain their positions through the transition, and no action is required on their part.

The information is based on a company press release statement.

You May Also Be Interested In

• Alphabet Sees FY26 Capex $195B To $205B, Saw $180B To $190B
• Sigma Lithium faces $540,000 in fines, begins TAC talks in Brazil
• Steakholder Foods adjusts ADS ratio in a 1-for-3 reverse split